0001104659-13-080067.txt : 20131101
0001104659-13-080067.hdr.sgml : 20131101
20131101161308
ACCESSION NUMBER: 0001104659-13-080067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131031
FILED AS OF DATE: 20131101
DATE AS OF CHANGE: 20131101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED INC
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 DEER PARK DRIVE
STREET 2: SUITE C
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
BUSINESS PHONE: 732-997-4600
MAIL ADDRESS:
STREET 1: 9 DEER PARK DRIVE
STREET 2: SUITE C
CITY: MONMOUTH JUNCTION
STATE: NJ
ZIP: 08852
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewis William
CENTRAL INDEX KEY: 0001402051
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 131186063
MAIL ADDRESS:
STREET 1: C/O AEGERION PHARMACEUTICALS, INC.
STREET 2: 1140 ROUTE 22 EAST, SUITE 304
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
4
1
a4.xml
4
X0306
4
2013-10-31
0
0001104506
INSMED INC
INSM
0001402051
Lewis William
C/O INSMED INC
9 DEER PARK DRIVE, SUITE C
MONMOUTH JUNCTION
NJ
08852
1
1
0
0
President and CEO
Common Stock
2013-11-01
4
P
0
5233
14.28
A
46972
D
Stock Option-Right to Buy
3.40
2013-09-10
2022-09-10
Common Stock
708314
708314
D
Stock Option-Right to Buy
4.55
2013-09-28
2022-09-28
Common Stock
186170
186170
D
Stock Option-Right to Buy
12.44
2014-05-23
2023-05-23
Common Stock
83333
83333
D
Stock Option-Right to Buy
12.44
2023-05-23
Common Stock
166667
166667
D
Stock Option-Right to Buy
14.24
2014-10-31
2013-10-31
Common Stock
250000
250000
D
Open market purchase pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.15 to $14.46, inclusive. The reporting person undertakes to provide to Insmed Incorporated, any security holder of Insmed Incorporated or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
These options become exercisable with respect to 25% of the shares of common stock subject to this grant on September 10, 2013, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of September 10, 2013 thereafter through September 10, 2016.
These options become exercisable with respect to 25% of the shares of common stock subject to this grant on September 28, 2013, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of September 28, 2013 thereafter through September 28, 2016.
These options become exercisable with respect to 25% of the shares of common stock subject to this grant on May 23, 2014, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of May 23, 2014 thereafter through May 23, 2017.
These options become exercisable upon the achievement of certain performance criteria.
These options become exercisable with respect to 25% of the shares of common stock subject to this grant on October 31, 2014, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of October 31, 2014 thereafter through October 31, 2017.
/s/ Christine Pellizzari, as attorney-in-fact for William Lewis
2013-11-01